This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to ...

Commissioners visit UD-based NIIMBL, where public-private partnerships promote innovation, workforce development ...

The notion that we can simultaneously demand expedited approvals while gutting the agency is misguided.

Officials with Arvinas, a New Haven-based biotechnology firm, announced Thursday that the company is laying off 131 workers at the end of June, including 92 in Connecticut. The company announced its ...

The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final report and action plan, “urging Congressional action to bring the full ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, ...

VelaVigo Bio has landed its second deal in six months, offloading ex-China rights to a bispecific to Ollin Biosciences for up ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The BioScience Alliance in Westlake Village, Ventura County’s 2nd District, the Economic Development Collaborative and India’s Atal Incubation Centre have entered into an agreement aimed at ...

Uncertainties surrounding the U.S. pharmaceutical sector and the turbulent development in global stock markets have led to ...